CAPTIQUE INJECTABLE GEL
FDA premarket approval P030032/S002 · decided 2004-11-12
Approval details
- PMA number
- P030032
- Supplement
- S002
- Supplement type
- Normal 180 Day Track
- Trade name
- CAPTIQUE INJECTABLE GEL
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Genzyme Biosurgery
- Date received
- 2004-07-28
- Decision date
- 2004-11-12
- Days to decision
- 107 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Cambridge, MA
- Statement
- APPROVAL FOR A NEW SOURCE OF HYALURONIC ACID OBTAINED FROM BACTERIAL FERMENTATION. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME CAPTIQUE AND IS INDICATED FOR INJECTION INTO THE MID TO DEEP DERMIS FOR CORRECTION OF MODERATE TO SEVERE FACIAL WRINKLES AND FOLDS (SUCH AS NASOLABIAL FOLDS).
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| S-1150 PLEUR-EVAC SAHARA PLUS CONTINUOUS REINFUSION AUTOTRANSFUSION SYSTEM (K031554) | Genzyme Biosurgery | 2003-07-25 |
| MONODEK SYNTHETIC ABSORBABLE SURGICAL SUTURE (K030212) | Genzyme Biosurgery | 2003-03-27 |
| RADLITE TISSUE RETRACTOR SYSTEM (K022989) | Genzyme Biosurgery | 2002-11-25 |
| SAPH-LOOP LIGATING LOOP (K022410) | Genzyme Biosurgery | 2002-08-20 |